Inspire Medical stock price target lowered to $125 at RBC on 2026 guidance
NegativeFinancial Markets

Inspire Medical's stock price target has been lowered to $125 by RBC, reflecting concerns over the company's guidance for 2026. This adjustment is significant as it indicates potential challenges ahead for Inspire Medical, which could impact investor confidence and market performance. Keeping an eye on how the company addresses these challenges will be crucial for stakeholders.
— Curated by the World Pulse Now AI Editorial System








